| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
| filingDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103987708-B |
| titleOfInvention |
The derivant of 4-hydroxyl-1,2,3,4-naphthane-1-base urea and the purposes in treatment of respiratory diseases thereof |
| abstract |
Disclose the compound and pharmaceutically acceptable salt thereof with [1,2,4] triazol [4,3-a] pyridine groups。Described compound is p38MAPK inhibitor, and it can be used as antiinflammatory in the treatment of respiratory tract disease and Other diseases。 |
| priorityDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |